MedTrace Logo

10-week Leucine Supplementation in Cerebral Palsy

NCT03668548 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-09-12

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of 10-weeks leucine supplementation on muscle growth, metabolism, body composition, inflammation and wellbeing in adolescents and young adults with CP.

Conditions

  • Cerebral Palsy
  • Cerebral Palsy, Mixed
  • Cerebral Palsy Ataxic

Interventions

DIETARY_SUPPLEMENT

Leucine

192 mg/kg body mass/day

DIETARY_SUPPLEMENT

Placebo

A taste and calorie-matched placebo

Sponsors & Collaborators

  • University of Gloucestershire

    collaborator OTHER

  • St Mary's University College

    lead OTHER

Principal Investigators

  • Nicola Theis, PhD · University of Gloucestershire

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-20
Primary Completion
2018-10-22
Completion
2018-10-22

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03668548 on ClinicalTrials.gov